Saji S - Search Results

1

Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study.

Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S. Kawaguchi H, et al. Among authors: saji s. Curr Med Res Opin. 2018 Jan;34(1):49-54. doi: 10.1080/03007995.2017.1400426. Epub 2017 Nov 21. Curr Med Res Opin. 2018. PMID: 29095648

2

MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells.

Saji S, Okumura N, Eguchi H, Nakashima S, Suzuki A, Toi M, Nozawa Y, Saji S, Hayashi S. Saji S, et al. Biochem Biophys Res Commun. 2001 Feb 16;281(1):259-65. doi: 10.1006/bbrc.2001.4339. Biochem Biophys Res Commun. 2001. PMID: 11178989

3

[Efficacy of biweekly paclitaxel therapy in advanced or recurrent breast cancer].

Kuroi K, Tanaka C, Bando H, Saji S, Hayashi K, Toi M. Kuroi K, et al. Among authors: saji s. Gan To Kagaku Ryoho. 2002 Jan;29(1):55-60. Gan To Kagaku Ryoho. 2002. PMID: 11816478 Japanese.

4

Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.

Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson JA, Toi M. Saji S, et al. Cancer Res. 2002 Sep 1;62(17):4849-53. Cancer Res. 2002. PMID: 12208729

5

Clinical impact of assay of estrogen receptor beta cx in breast cancer.

Saji S, Omoto Y, Shimizu C, Horiguchi S, Watanabe T, Funata N, Hayash S, Gustafsson JA, Toi M. Saji S, et al. Breast Cancer. 2002;9(4):303-7. doi: 10.1007/BF02967608. Breast Cancer. 2002. PMID: 12459710

6

[Current indications for mastectomy in patients with breast cancer].

Nakanishi C, Toi M, Saji S, Bando H. Nakanishi C, et al. Among authors: saji s. Nihon Geka Gakkai Zasshi. 2002 Nov;103(11):821-4. Nihon Geka Gakkai Zasshi. 2002. PMID: 12478859 Japanese.

7

Weekly schedule of docetaxel in breast cancer: evaluation of response and toxicity.

Kuroi K, Bando H, Saji S, Toi M. Kuroi K, et al. Among authors: saji s. Breast Cancer. 2003;10(1):10-4. doi: 10.1007/BF02967619. Breast Cancer. 2003. PMID: 12525757 Review.

8

Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma.

Saji H, Toi M, Saji S, Koike M, Kohno K, Kuwano M. Saji H, et al. Among authors: saji s. Cancer Lett. 2003 Feb 20;190(2):191-7. doi: 10.1016/s0304-3835(02)00590-6. Cancer Lett. 2003. PMID: 12565174

9

Decision tree and paradigms of primary breast cancer: changes elicited by preoperative therapy.

Toi M, Bando H, Saji S. Toi M, et al. Among authors: saji s. Med Sci Monit. 2003 May;9(5):RA90-5. Med Sci Monit. 2003. PMID: 12761467 Review.

10

Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues.

Yamamoto Y, Yamashita J, Toi M, Muta M, Nagai S, Hanai N, Furuya A, Osawa Y, Saji S, Ogawa M. Yamamoto Y, et al. Among authors: saji s. Oncol Rep. 2003 Jul-Aug;10(4):791-6. Oncol Rep. 2003. PMID: 12792725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters